Immix Biopharma, Inc.IMMXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+207.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
29.2x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.08 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 0.00 | +100.3% |
| 2020 | -0.87 | +22.9% |
| 2019 | -1.12 | - |